These data collectively underscore that the dual modifications of E1A and E4orf6/7 in ICVB-1042 reduce its capacity to induce S-phase cell cycle checkpoint transition in non-cancerous cells, increasing its reliance on dysregulated E2F1 transcriptional activity in tumor cells. The gene discussed is E2F1; the disease is neoplasm.